15:59 Dec 26
Biocon Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Biocon Ltd.
66/100 High Financial Strength
Quality63/100 Affordable Valuation
Valuation47/100 Technically Neutral
TechnicalSWOT
Strength
5
Weakness
3
Opportunity
1
Threat
1
41.59K
Market Cap (Cr)
28.90
PE Ratio
1.97
Price to Book Ratio
47.7
RSI
6.92 %
Net Profit Margin
Rating Based on 3 Analysts
Buy
67%
Hold
33%
Sell
0%
Buy
Analyst Price Target
The average price target is 382 with a high estimate of 400 and low estimate of 370
Current 346.45
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
